mucopolysaccharidosis Ih

Summary
Synonym
  • Dysostosis multiplex syndrome
  • Hurler disease MPS type 1H
  • Hurler-Pfaundler syndrome
  • L-iduronidase deficiency, Hurler type
  • MPS1-H
  • Mucopolysaccharidosis type I severe form
  • dysostosis multiplex
  • gargoylism
Definition
A mucopolysaccharidosis I characterized by a severe phenotype that includes dysostosis multiplex, cognitive impairment, heart disease, respiratory problems, corneal clouding, hepatosplenomegaly, coarse facies and reduced life expectancy that has_material_basis_in homozygous or compound heterozygous mutation in the IDUA gene on chromosome 4p16.3.
Super Class
autosomal recessive disease mucopolysaccharidosis I
Disease Ontology
DOID:0111390
Mondo Disease Ontology
MeSH
UMLS
NCI Thesaurus
ORDO
OMIM
GARD
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
3425 IDUA alpha-L-iduronidase
Displaying 1 entry
Gene ID Gene Symbol Description Source
15932 Idua iduronidase, alpha-L
Displaying 1 entry
Gene ID Gene Symbol Description Source
34544 Idua alpha-L-iduronidase
Related Glycoprotein
The Human Phenotype Ontology
Displaying entries 1 - 10 of 98 in total
HPO ID HPO Term
HP:0000158 Macroglossia
HP:0000232 Everted lower lip vermilion
HP:0000238 Hydrocephalus
HP:0000268 Dolichocephaly
HP:0000280 Coarse facial features
HP:0000293 Full cheeks
HP:0000365 Hearing impairment
HP:0000431 Wide nasal bridge
HP:0000463 Anteverted nares
HP:0000470 Short neck
Displaying 1 entry
Gene ID Gene Symbol Description
3425 IDUA alpha-L-iduronidase

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024